| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUGGGCAGCCGGCGGGCUCCGAGGCCGUGAGCGCAAAGCCUCAGGCCCC… | 1454 nt | 0.5832 | |
| GUGGGCAGCCGGCGGGCUCCGAGGCCGUGAGCGCAAAGCCUCAGGCCCC… | 1625 nt | 0.5852 | |
| GUGGGCAGCCGGCGGGCUCCGAGGCCGUGAGCGCAAAGCCUCAGGCCCC… | 1612 nt | 0.5875 | |
| GUGGGCAGCCGGCGGGCUCCGAGGCCGUGAGCGCAAAGCCUCAGGCCCC… | 1695 nt | 0.5870 | |
| GUGGGCAGCCGGCGGGCUCCGAGGCCGUGAGCGCAAAGCCUCAGGCCCC… | 1532 nt | 0.5862 | |
| GUGGGCAGCCGGCGGGCUCCGAGGCCGUGAGCGCAAAGCCUCAGGCCCC… | 1672 nt | 0.5885 | |
| GUGGGCAGCCGGCGGGCUCCGAGGCCGUGAGCGCAAAGCCUCAGGCCCC… | 1579 nt | 0.5896 |
This gene encodes a receptor protein that interacts with a variety of psychotomimetic drugs, including cocaine and amphetamines. The receptor is believed to play an important role in the cellular functions of various tissues associated with the endocrine, immune, and nervous systems. As indicated by its previous name, opioid receptor sigma 1 (OPRS1), the product of this gene was erroneously thought to function as an opioid receptor; it is now thought to be a non-opioid receptor. Mutations in this gene has been associated with juvenile amyotrophic lateral sclerosis 16. Alternative splicing of this gene results in transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2013]
A study in mice demonstrated that methamphetamine or LPS administration increased SIGMAR1 expression in astrocytes, which was associated with astrocyte activation, autophagy induction, and ER stress [Huang et al. DOI:10.1080/15548627.2017.1356975].